Natural products from Garcinia brasiliensis as Leishmania protease inhibitors

Journal of Medicinal Food

Volumn 14, Issue 6, 2011, Pages 557-562

  Pereira, Ivan O ^a,b   Assis, Diego M ^c   Juliano, Maria A ^c   Cunha, Rodrigo L O R ^c   Barbieri, Clara L ^c   Do Sacramento, Luis V S ^b   Marques, Marcos J ^a   Dos Santos, Marcelo H ^a  

^a FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Garcinia brasiliensis; Leishmania; proteases

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; ANTIPROTOZOAL AGENT; FUKUGETIN; GARCINIA BRASILIENSIS EXTRACT; HEXANE; PLANT EXTRACT; PROTEINASE; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME INHIBITION; FRUIT; GARCINIA; GARCINIA BRASILIENSIS; IC 50; IN VITRO STUDY; LEISHMANIA; LEISHMANIASIS; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROMASTIGOTE;

ANIMALS; ANTIPROTOZOAL AGENTS; BRAZIL; FRUIT; GARCINIA; HUMANS; INHIBITORY CONCENTRATION 50; LEISHMANIA; LEISHMANIASIS; PEPTIDE HYDROLASES; PLANT EXTRACTS; PROTEASE INHIBITORS; PROTOZOAN PROTEINS; RATS;

GARCINIA; LEISHMANIA AMAZONENSIS; MAMMALIA; PROTOZOA;

EID: 79957817942     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2010.0018     Document Type: Article

References (38)

1. Herwaldt BL: Leishmaniasis. Lancet 1999;354:1191-1199.
2. Rosenthal PJ, Kim K, McKerrow JH, Leech JH: Identification of three stage-specific proteinases from Plasmodium palcifarum. J Exp Med 1999;166:816-821.
3. Sadij M, McKerrow JH: Cysteine proteases of parasitic organisms. Mol Biochem Parasitol 2002;120:1-21.
4. Hide G, Mottram JC, Coombs GH, Holmes PH: Proteases in trypanosomatids: biology and control. In: Trypanosomiasis and leishmaniasis. London, CAB International, 1997, pp 176-197.
5. Mottram JC, Brooks DR, Coombs GH: Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Curr Opin Microbiol 1998;1:445-460.
6. Mottram JC, Coombs GH, Alexander J: Cysteine peptidases as virulence factors of Leishmania. Curr Opin Microbiol 2004;7:375-381.
7. McKerrow JH, McGrath ME, Engel JC: The cysteine protease of Trypanosoma cruzi as a model for antiparasitic drug design. Parasitol Today 1995;11:279-282.
8. Robertson CD, Coombs GH, North MJ, Mottram JC: Parasite cysteine proteinases. Drug Disc Design 1996;6:99-118.
9. Selzer PM, Chen XW, Chan VJ: Leishmania major molecular modeling of cysteine proteases and prediction of new nonpeptide inhibitors. Exp Parasitol 1997;87:212-221.
10. Desai PV, Patny A, Sabnis Y, et al.: Identification of novel parasitic cysteine protease inhibitors using virtual screening. J Med Chem 2004;16:6609-6615.
11. Croft SL, Coombs GH: Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol 2003;19:502-508.
12. Chan-Bacab MJ, Peña-Rodríguez LM: Plant natural products with leishmanicidal activity. Nat Prod Rep 2001;18:674-688.
13. Kayser O, Kiderlen AF, Laatsch H, Croft SL: In vitro leishmanicidal activity of monomeric and dimeric naphtoquinones. Acta Tropica 2000;76:131-138.
14. Sauvain M, Kunesch N, Poisson J, et al.: Isolation of leishmanicidal triterpenes and lignans from Amazonian liana Doliocorpus dentatus (Dilleniaceae). Phytother Res 1996;10:1-4.
15. Delorenzi JC, Attias M, Gattass CR, et al.: Antileishmanial activity of an indole alkaloid from Peschiera australis. Antimicrob Agents Chemother 2001;45:1349-1354.
16. Torres-Santos EC, Moreira DL, Kaplan MAC, et al.: Selective effect of 2', 6'-di-hydroxy-4'-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis. Antimicrob Agents Chemother 1999;43:1234-1241.
17. Fumiko ABE, Nagafuji S, Okabe H: Trypanocidal constituents in plants 3.1. Leaves of Garcinia intermedia and heartwood of Calophyllum brasiliense. Biol Pharm Bull 2004;27:141-143.
18. Pereira IO, Marques MJ, Pavan ALR, et al.: Leishmanicidal activity of benzophenones and extracts from Garcinia brasiliensis Mart. Fruits. Phytomedicine 2010;17:339-345.
19. Martins FT, Assis DM, Santos MH, et al.: Natural polyprenylated benzophenones inhibiting cysteine and serine proteases. Eur J Med Chem 2009;44:1230-1239.
20. Monache GD, Monache FD, Waterman PG, et al.: Minor xanthones from Rheedia gardneriana. Phytochemistry 1984;23:1757-1759.
21. Gustafson KR, Blunt JW, Munro MHG: The guttferones, HIV-inhibitory benzophenones from symphonia globulifera, Garcinia livingstonei, Garcinia ovalifolia and Clusia rosea. Tetrahedron 1992;48:10093-10102.
22. Barrett AJ, Kirschke H: Cathepsin B, cathepsin H and cathepsin L. Methods Enzymol 1981;80:535-561.
23. Melo RL, Alves LC, Del Nery E, et al.: Synthesis and hydrolysis by cysteine and serine proteases of short internally quenched fluorogenic peptides. Anal Biochem 2001;293:71-77.
24. Derogis PBMC, Martins FT, De Souza TC, et al.: Complete assignment of the 1H and 13C NMR spectra of garciniaphenone and keto-enol equilibrium statements for prenylated benzophenones. Magn Reson Chem 2008;46:278-282.
25. Konoshima M, Ikeshiro Y, Nishinaga A, et al.: The constitution of flavonoids from hook.f. Tetr Lett 1969;10:121-124.
26. Botta B, Mac-Quhae MM, Monache GM, et al.: Chemical investigation of the genus Rheedia. V. Bi-flavonoids and xanthochymol. J Nat Prod 1984;47:1053-1064.
27. Martinez E, Moreno-Murillo B, Delle Monache F: Estudio quimico y actividad biologica de tres especies de la familia rutaceae. Revista Colombiana de Química 1996;25:15-27.
28. Tripathi S, Singh N, Shakya S, et al.: Landrace/gender based differences in phenol and thiocyanate contents and biological activity in Piper betle L. Curr Sci 2006;91:746-749.
29. Mossman T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Meth 1983;65:55-63.
30. World Health Organization. Leishmaniasis: geographical distribution. www.who.int/emc/diseases/leish/leisgeo1.html (accessed April 2011).
31. World Health Organization: Leishmaniasis: the disease and its impact. www.who.int/emc/diseases/leish/leisdis1.html (accessed April 2011).
32. Croft SL, Barrett MP, Urbina JA: Chemotherapy of trypanosomiases and leishmaniasis. Trends Parasitol 2005;21:508-512.
33. Ferreira ICP, Lonardoni MVC, Machado GMC, et al.: Antileishmanial acitivity of alkaloidal extract from Aspidosperma ramiflorum. Mem Inst Oswaldo Cruz 2004;99:1-3.
34. Araújo CAC, Alegrio LV, Leon LL: Antileishmanial activity of compounds extracted and characterized from Centrolobium sclerophyllum. Phytochemistry 1998;49:751-754.
35. Khaw M, Panosian CB: Human antiprotozoal therapy: past, present and future. Clin Microbiol Rev 1995;8:427-439.
36. Edzard E: Harmless herbs? A review of the recent literarure. Am J Med 1998;104:170-178.
37. Marcucci MC, Ferreres F, García-Viguera C, et al.: Phenolic compounds from Brazilian propolis with pharmacological activities. J Ethnopharmacol 2001;74:105-112.
38. Urzúa A, Echeverría J, Rezende MC, Wilkens M: Antibacterial properties of 3 H-Spiro[1-benzofuran-2, 1'-cyclohexane] derivatives from Heliotropium filifolium. Molecules 2008;13:2385-2393.